Healthcare and Societal Costs in Patients with COPD and Breathlessness after Completion of a Comprehensive Rehabilitation Program

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2020 report); 2020. Available from: https://goldcopd.org/.
   Google Scholar
• GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596. DOI:https://doi.org/10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1459–1544. DOI:https://doi.org/10.1016/S0140-6736(16)31012-1
   PubMed Web of Science ®Google Scholar
• Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. DOI:https://doi.org/10.1183/09031936.06.00025805
   PubMed Web of Science ®Google Scholar
• Janssen DJ, Spruit MA, Wouters EF, et al. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med. 2008;22(8):938–948. DOI:https://doi.org/10.1177/0269216308096906
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581–586. DOI:https://doi.org/10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Dodd JW, Marns PL, Clark AL, et al. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD. 2012;9(4):390–394. DOI:https://doi.org/10.3109/15412555.2012.671869
   PubMedGoogle Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. DOI:https://doi.org/10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Kirsch F, Schramm A, Schwarzkopf L, et al. Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study. Respir Res. 2019;20(1):215–215. DOI:https://doi.org/10.1186/s12931-019-1179-7
   PubMed Web of Science ®Google Scholar
• Wouters EF. The burden of COPD in The Netherlands: results from the Confronting COPD survey. Respir Med. 2003;97(Suppl C):S51–S59. DOI:https://doi.org/10.1016/s0954-6111(03)80025-2
   PubMed Web of Science ®Google Scholar
• Dzingina MD, Reilly CC, Bausewein C, et al. Variations in the cost of formal and informal health care for patients with advanced chronic disease and refractory breathlessness: a cross-sectional secondary analysis. Palliat Med. 2017;31(4):369–377. DOI:https://doi.org/10.1177/0269216317690994
   PubMed Web of Science ®Google Scholar
• Stephenson JJ, Wertz D, Gu T, et al. Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting. COPD. 2017;12:1947–1959. DOI:https://doi.org/10.2147/COPD.S134618
   Google Scholar
• van Boven JFM, Vegter S, van der Molen T, et al. COPD in the working age population: the economic impact on both patients and government. COPD. 2013;10(6):629–639. DOI:https://doi.org/10.3109/15412555.2013.813446
   PubMedGoogle Scholar
• GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1789–1858. DOI:https://doi.org/10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. DOI:https://doi.org/10.1164/rccm.201209-1665OC
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. DOI:https://doi.org/10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Zorginstituut Nederland. Kostenhandleiding: methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. 2015.
   Google Scholar
• Nederlandse Zorg Autoriteit. Tarievenlijst Eerstelijnsdiagnostiek. 2013.
   Google Scholar
• Zorginstituut Nederland. Medicijnkosten.nl [cited 2019 Jul 1]. Available at: https://www.medicijnkosten.nl/.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease 2019 Report. 2019.
   Google Scholar
• Suijkerbuijk AWM, de Wit GAA, Wijga AH, et al. Societal costs of asthma, COPD and respiratory allergy [Maatschappelijke kosten van astma, COPD en respiratoire allergie]. Ned Tijdschr Geneeskd. 2013;157(46):A6562–A6562.
   PubMedGoogle Scholar
• Hoogendoorn M, Feenstra TL, Rutten-van Mölken MPMH. Projections of future resource use and the costs of asthma and COPD in the Netherlands [Toekomstprojecties van het zorggebruik en de kosten van astma en COPD in Nederland]. Ned Tijdschr Geneeskd. 2006;150(22):1243–1250.
   PubMedGoogle Scholar
• Janssen DJ, Spruit MA, Uszko-Lencer NH, et al. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med. 2011;14(6):735–743. DOI:https://doi.org/10.1089/jpm.2010.0479
   PubMed Web of Science ®Google Scholar
• Rocker G, Horton R, Currow D, et al. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax 2009;64(10):910–915. DOI:https://doi.org/10.1136/thx.2009.116699
   PubMed Web of Science ®Google Scholar
• Janssen DJA, Johnson MJ. Palliative treatment of chronic breathlessness syndrome: the need for P5 medicine. Thorax 2020;75(1):2–3. DOI:https://doi.org/10.1136/thoraxjnl-2019-214008
   PubMed Web of Science ®Google Scholar
• Lanken PN, Terry PB, Delisser HM, et al.; ATS End-of-Life Care Task Force. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912–927. DOI:https://doi.org/10.1164/rccm.200605-587ST
   PubMed Web of Science ®Google Scholar
• Marciniuk DD, Goodridge D, Hernandez P, et al.; Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18(2):69–78. DOI:https://doi.org/10.1155/2011/745047
   PubMed Web of Science ®Google Scholar
• Ekstrom M, Bajwah S, Bland JM, et al. One evidence base; three stories: do opioids relieve chronic breathlessness? Thorax 2018;73(1):88–90. DOI:https://doi.org/10.1136/thoraxjnl-2016-209868
   PubMed Web of Science ®Google Scholar
• Ahmadi Z, Bernelid E, Currow DC, et al. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study. Int J Chron Obstruct Pulmon Dis. 2016;11:2651–2657. DOI:https://doi.org/10.2147/COPD.S112484
   PubMed Web of Science ®Google Scholar
• Ahmadi Z. The burden of chronic breathlessness across the population. Curr Opin Support Palliat Care. 2018;12(3):214–218. DOI:https://doi.org/10.1097/SPC.0000000000000364
   PubMed Web of Science ®Google Scholar
• Brighton LJ, Miller S, Farquhar M, et al. Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis. Thorax 2019;74(3):270–281. DOI:https://doi.org/10.1136/thoraxjnl-2018-211589
   PubMed Web of Science ®Google Scholar